Viking Therapeutics, Inc. (VKTX)
28.49
+0.76
(+2.74%)
USD |
NASDAQ |
Oct 09, 16:00
28.55
+0.06
(+0.21%)
After-Hours: 20:00
Viking Therapeutics Total Return Level : 27.73 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 27.73 |
| October 07, 2026 | 28.54 |
| October 06, 2026 | 28.38 |
| October 05, 2026 | 29.28 |
| October 02, 2026 | 29.94 |
| October 01, 2026 | 30.51 |
| September 30, 2026 | 32.60 |
| September 29, 2026 | 31.81 |
| September 28, 2026 | 33.03 |
| September 25, 2026 | 35.56 |
| September 24, 2026 | 36.75 |
| September 23, 2026 | 41.65 |
| September 22, 2026 | 40.85 |
| September 21, 2026 | 30.11 |
| September 18, 2026 | 28.99 |
| September 17, 2026 | 29.36 |
| September 16, 2026 | 29.52 |
| September 15, 2026 | 29.95 |
| September 14, 2026 | 31.53 |
| September 11, 2026 | 31.98 |
| September 10, 2026 | 32.13 |
| September 09, 2026 | 32.70 |
| September 08, 2026 | 33.68 |
| September 04, 2026 | 34.87 |
| September 03, 2026 | 33.98 |
| Date | Value |
|---|---|
| September 02, 2026 | 33.50 |
| September 01, 2026 | 33.67 |
| August 31, 2026 | 32.78 |
| August 28, 2026 | 32.16 |
| August 27, 2026 | 33.86 |
| August 26, 2026 | 34.38 |
| August 25, 2026 | 34.17 |
| August 24, 2026 | 33.23 |
| August 21, 2026 | 33.89 |
| August 20, 2026 | 34.36 |
| August 19, 2026 | 35.98 |
| August 18, 2026 | 33.37 |
| August 17, 2026 | 33.63 |
| August 14, 2026 | 33.19 |
| August 13, 2026 | 32.94 |
| August 12, 2026 | 34.02 |
| August 11, 2026 | 33.80 |
| August 10, 2026 | 34.44 |
| August 07, 2026 | 34.26 |
| August 06, 2026 | 33.30 |
| August 05, 2026 | 33.51 |
| August 04, 2026 | 32.94 |
| August 03, 2026 | 32.61 |
| July 31, 2026 | 31.74 |
| July 30, 2026 | 33.11 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 503.25 |
| Eli Lilly & Co. | 3090.33 |
| Regeneron Pharmaceuticals, Inc. | 746.43 |
| Amgen, Inc. | 610.11 |
| Ironwood Pharmaceuticals, Inc. | 3.87 |